Pharmacognosy Magazine · 2017 · 16 citations · 22 references
Life SciencesNeuroscienceNutritional SciencesApoptosisNeurochemistryNeuropharmacologyApoptosis In NeurodegenerationFatty Acid MetabolismLipid MetabolismLipid PeroxidationNeuronal Cell DeathNeuroprotectionAnti-inflammatory MechanismsDietary Fatty AcidsFatty AcidsNeural Cell DeathNeuroprotective AgentsNeuroprotective Apoptosis ModulationNeuroprotective Natural ProductsProtective Antioxidants
OBJECTIVE: Parkinson's disease, a slowly progressive neurological disease, is associated with degeneration of the basal ganglia of the brain and a deficiency of the neurotransmitter dopamine. The main aspects of researches are the protection of normal neurons against degeneration. Fatty acids (FAs), the key structural elements of dietary lipids, are carboxylic straight chains and notable parameters in nutritional and industrial usefulness of a plant. MATERIALS AND METHODS: ) in rat pheochromocytoma cell line (PC12) as a neural cell death model. The experiment consisted of examination of cell viability assessment, mitochondrial membrane potential (MMP), caspase-3 and -9 activity, and measurement of cyclooxygenase (COX) activity. RESULTS: in PC12 cells. CONCLUSION: may exert cytoprotective effects through their anti-apoptotic and anti-inflammation actions and could be regarded as a dietary supplement. SUMMARY: ; OA: Oleic acid; PA: Palmitic acid; PBS: Phosphate buffer saline; PC12: Rat pheochromocytoma cell line; PD: Parkinson's disease; PDA: Photo diode array detector; PGE2: Prostaglandin E2; TLC: Thin layer chromatography; TMPD: N,N,N',N'-tetramethyl-p-phenylenediamine; USA: United states of America.
22